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Abstract Upon in vitro myogenesis, the intermediate filament
protein vimentin is replaced by desmin, the switch in gene
expression occurring essentially at the transcriptional level.
Trying to elucidate the molecular mechanisms of this genetic
control, we show here that the vimentin promoter is specifically
recognized and activated by a protein most probably identical to
H4TF-1, and that this factor is present in proliferating myoblasts
but disappears upon fusion of these cells into multinucleated
myotubes. Our results suggest that H4TF-1 is a differentiation
stage-specific factor involved in the downregulation of vimentin
gene expression during myogenesis. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
During vertebrate development, the synthesis of intermedi-
ate ¢lament (IF) proteins, a superfamily of around 50 mem-
bers with more or less restricted tissue speci¢city, undergoes a
complex regulation. In the embryo, vimentin is speci¢c of the
mesoderm. In the adult organism, it is maintained in some
mesodermal derivatives, while in others it is replaced by dis-
tinct IFs. In mammalian adult skeletal muscle, for instance,
IFs are made of desmin [1]. Vimentin is present in human fetal
skeletal muscle until 36 weeks of gestation but its proportion
progressively decreases in favor of desmin during development
[2]. Upon rat skeletal muscle regeneration, vimentin synthesis
is observed in activated satellite cells, it increases at the begin-
ning of regeneration, and then decreases to become undetect-
able in mature, regenerated ¢bers [3]. In myogenic cell lines in
vitro, proliferating myoblasts stop producing vimentin when
they are induced to fuse into multinucleated myotubes that
acquire numerous characters of di¡erentiated muscle cells.
Functional study of the human vimentin promoter has led
us and others to identify positive and negative regulatory
elements, some of which may be involved in the control of
vimentin gene expression during cell di¡erentiation (Fig. 1;
for a review, see [4]). Two AP1 and an NF-UB binding sites
activate the vimentin promoter in proliferating cells [5], and a
negative element, NE1, counteracts the positive e¡ect of NF-
UB [6]. Both positive elements may become inactive during
myogenesis to allow downregulation of vimentin synthesis,
but to date it is not yet possible to say what regulatory ele-
ments are responsible for all aspects of the complex develop-
mental control of vimentin gene transcription.
More recently, we characterized a short region of the vi-
mentin promoter, including (i) a negative element, NE2, which
might reinforce vimentin gene expression blockade in di¡er-
entiated muscle cells [7] and (ii) a sequence we named H4
motif, homologous to the binding site of transactivating fac-
tor H4TF-1 [8]. Here, we show that a protein, most probably
H4TF-1 itself, speci¢cally recognizes the vimentin H4 motif,
and that this factor is present in proliferating myoblasts but is
not detected in di¡erentiated myotubes. Besides, the vimentin
H4 motif has decreased transcriptional activity in myotubes,
suggesting that it contributes to the negative regulation of
vimentin gene expression upon muscle di¡erentiation.
Through our results, it appears that a histone gene transcrip-
tion factor may be recruited to the complex vimentin pro-
moter to participate in di¡erentiation stage-speci¢c gene ex-
pression, this factor being actually lost upon in vitro
myogenesis.
2. Materials and methods
2.1. Cell culture
Murine C2C12 myoblasts and C3H 10T1/2 ¢broblasts were ob-
tained from the ECACC (Porton Down, UK). Myoblasts were grown
in DMEM+20% fetal bovine serum (Life Technologies). Myotubes
were obtained by switching con£uent myoblasts to DMEM+2% horse
serum (Life Technologies) for 3 days. Fibroblasts were grown in
MEM+10% fetal bovine serum.
2.2. Transfection and reporter gene expression assay
pVimCAT plasmids were derived from p1757vimCAT, which in-
cludes the bacterial chloramphenicol acetyltransferase (CAT) gene
under the control of the human vimentin promoter (nucleotides (nt)
31757 to +78). Two 5P-deletion mutants, p642vimCAT and p606vim-
CAT, were generated from p1757vimCAT by PCR (upstream borders
of vimentin sequence 3642 and 3606, respectively). Transfection in-
ternal reference was provided by pEF1lacZ plasmid, containing the
bacterial lacZ gene under the control of the human EF1K promoter.
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C2C12 myoblasts were transfected 24 h after seeding, using 7.5 Wl
Fugene 6 transfection reagent (Roche Diagnostics), 2.25 Wg pVimCAT
and 0.25 Wg pEF1lacZ per 25 cm2 £ask. 48 h later, cells were either
lysed (transfected myoblasts), or allowed to di¡erentiate for 72 h
before lysis (transfected myotubes). CAT and L-galactosidase were
assayed by enzyme-linked immunosorbent assay, according to the
manufacturer’s instructions (Roche Diagnostics). Experiments were
done three times, with each point in triplicate.
2.3. Preparation of whole nuclear extracts
All steps were performed at 4‡C with bu¡ers supplemented just
before use with 0.15 mM spermidine, 0.15 mM spermine, 1 mM di-
thiothreitol (DTT), 1 mM PMSF, 2 mM benzamidine (Sigma), and
Complete0 protease inhibitor mix (Roche Diagnostics). Cells were
washed, scraped and pelleted in phosphate-bu¡ered saline, suspended
in three volumes bu¡er A (20 mM HEPES pH 7, 0.15 mM EDTA,
0.15 mM EGTA, 10 mM KCl), and lysed with NP40 (1% ¢nal con-
centration). Released nuclei were stabilized by addition of one volume
bu¡er S (50 mM HEPES pH 7, 0.25 mM EDTA, 10 mM KCl, 70%
sucrose), pelleted, and washed in ¢ve volumes bu¡er B (10 mM
HEPES pH 8, 0.1 mM EDTA, 0.1 M NaCl, 25% glycerol). After
centrifugation, nuclei were gently suspended in one volume bu¡er C
(10 mM HEPES pH 8, 0.1 mM EDTA, 0.4 M NaCl, 25% glycerol)
and agitated 30 min at maximum speed on a Labnet Shaker 20.
Nuclei were discarded after high speed centrifugation and the super-
natant was stored in aliquots at 380‡C. Proteins were quanti¢ed by
the Bradford assay (Bio-Rad).
2.4. Electrophoretic mobility shift assay (EMSA)
Nuclear proteins (5 Wg) were incubated 10 min at 25‡C with 2.5 Wg
polydI-dCWpolydI-dC and 0.25 Wg calf thymus DNA in 20 mM
HEPES pH 8, 40 mM NaCl, 6 mM MgCl2, 7.5% glycerol. Cold,
competitor oligonucleotides, when used, were added at this step
(1.75 pmol). 35 fmol 32P-labeled probe was added for another 20
min incubation. The mixture was loaded onto a native 4% polyacryl-
amide gel (29:1) and electrophoresed 2 h at 10 V/cm in 0.125U TBE.
The gel was dried and analyzed by PhosphoImager.
The following double-stranded oligonucleotides were used: vH4,
human vimentin H4TF-1 motif (nt 3641 to 3612); hH4, H4TF-1
binding site of the human histone H4 gene (nt 3109 to 380);
mvH4 and mhH4, same oligonucleotides as vH4 and hH4 with four
point mutations to abolish factor interaction [8]; SP1, consensus SP1
target site (Promega). Probe vH4 was 5P-end-labeled with [Q-32P]ATP
(3000 Ci/mmol; NEN) by T4 polynucleotide kinase (Biolabs).
2.5. Southwestern blot
Nuclear proteins (100 Wg) were boiled in sample bu¡er (1% sodium
dodecyl sulphate (SDS), 50 mM Tris^HCl pH 7.5, 140 mM L-mer-
captoethanol, 10% glycerol, 0.001% pyronin Y) and electrophoresed
at 25 mA on an 0.1% SDS, 8% polyacrylamide gel in 50 mM Tris, 400
mM glycine, 0.1% SDS, in the presence of prestained molecular
weight standards (Sigma). They were electrotransferred to a nitrocel-
lulose sheet 2 h at 0.5 A in 25 mM Tris, 190 mM glycine, 20%
methanol, using a Bio-Rad transfer cell. The blot was blocked 1 h
at 37‡C in 5% non-fat dry milk, 50 mM Tris^HCl pH 7.5, 50 mM
NaCl, 0.1 mM EDTA, 1 mM DTT, equilibrated 5 min in binding
bu¡er (10 mM Tris^HCl pH 7.5, 50 mM NaCl, 0.1 mM EDTA, 1 mM
DTT), incubated 1 h at 25‡C with the vH4 probe (106 cpm/ml) in
20 ml binding bu¡er, washed three times in binding bu¡er, dried and
autoradiographed.
3. Results
3.1. Interaction of ¢broblast nuclear factors with the human
vimentin H4 motif
The vimentin H4 motif bears a perfect match to the binding
site of transcription factor H4TF-1: 5P-CCCTCCCCC-3P (nt
3630 to 3622), which appeared strongly protected in our
DNase I footprinting experiments [7]. To further characterize
the factor(s) involved, we analyzed protein^DNA interactions
obtained in vitro with nuclear extracts from proliferating C3H
10T1/2 ¢broblasts, in EMSA with the vH4 probe.
Two major, highly retarded complexes were produced (ar-
rowheads in Fig. 2, lane 1), the speci¢city of which was tested
with various competitor oligonucleotides. Formation of the
faster migrating complex (¢lled arrowhead) was abolished
by homologous competitor (vH4 ; lane 2), as well as by com-
petitor including the human histone H4 gene H4TF-1 binding
site (hH4 ; lane 5). When vH4 and hH4 oligonucleotides
beared point mutations reported to disrupt H4TF-1 binding
(5P-TCGTACTCC-3P instead of 5P-CCCTCCCCC-3P in mvH4
and mhH4 ; [8]), no competition occurred (lanes 3 and 6, re-
spectively). The complex remained also stable in the presence
of SP1 oligonucleotide, which we assayed because the GC-
rich H4 motif would potentially bind transcription factor
SP1 (lane 4). On the other hand, formation of the slower
migrating complex (open arrowhead) was reduced by the
¢ve oligonucleotides tested (lanes 2^6), and was clearly sup-
pressed by SP1 competitor (lane 4).
From these results we conclude that the vimentin H4 motif
speci¢cally binds a nuclear factor which might actually be
H4TF-1. This conclusion is supported by the fact that the
Fig. 1. Human vimentin gene promoter. Nucleotide numbering indi-
cates the boundaries of the main regulatory subregions identi¢ed
(+1: transcriptional start). Positive and negative control elements
are represented by gray ovals and hatched boxes, respectively.
Fig. 2. Fibroblast nuclear factor binding to the human vimentin
gene H4 motif. EMSA with C3H 10T1/2 ¢broblast whole nuclear
extract, using 32P-labeled vH4 probe, in the absence (lane 1) or pres-
ence of cold competitor oligonucleotides: vH4, mvH4, SP1, hH4
and mhH4 (lanes 2^6, respectively). Open and ¢lled arrowheads
point to protein^DNA complexes speci¢cally abolished by SP1 and
H4 competitors, respectively.
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faster migrating complex we obtain is abundant in the pres-
ence of 6 mM Mg2 and is considerably destabilized when
Mg2 concentration is lowered to 1 mM (not shown), exactly
as was demonstrated by Dailey et al. with H4TF-1 on the
human histone H4 gene [9]. The vimentin H4 motif also seems
to bind SP1, although with slightly reduced speci¢city.
3.2. Fate of nuclear factors binding to the vimentin H4 motif in
myogenic cells
Since the vimentin gene is active in myoblasts and becomes
repressed upon in vitro myogenesis, we searched for vimentin
H4 binding activities in the myogenic cell line C2C12, in pro-
liferation or di¡erentiation conditions. We performed EMSAs
to compare interactions of the vH4 probe with nuclear ex-
tracts from C3H 10T1/2 ¢broblasts, C2C12 myoblasts, and
C2C12 myotubes (Fig. 3A). The two protein^DNA complexes
described in the case of ¢broblasts (lane 1) were generated
with C2C12 myoblast nuclear extracts (lane 2). Anyhow,
when nuclear extracts from myotubes were used, the more
retarded complex remained unchanged, whereas the faster mi-
grating complex, that probably due to H4TF-1, became barely
detectable (lane 3). Disappearance of the faster migrating
complex in myotube extract was identically observed in the
presence of SP1 competitor oligonucleotide (Fig. 3B, compare
lanes 2 and 3).
To get more information about the factors involved, we
performed Southwestern blotting analysis of our nuclear ex-
tracts. A single polypeptide was recognized by the vH4 probe
in extracts from C2C12 myoblasts (Fig. 3C, lane 2). Its mo-
lecular weight is around 110^115 kDa, consistent with that
reported for H4TF-1 [10]. No signal was obtained with the
myotube extract (lane 3), the integrity of which was checked
with a vimentin NE2 probe revealing the presence of the neg-
ative element binding factors [7] (not shown). We conclude
that H4TF-1 (or at least a closely related polypeptide) is
present in C2C12 myoblasts, that it speci¢cally binds to the
vimentin promoter, and that this interaction is lost upon
muscle di¡erentiation.
3.3. Transcriptional activity of the vimentin H4 motif in C2C12
cells
To know whether loss of binding to the vimentin H4 motif
in£uences transcriptional activity of this sequence in C2C12
cells, we undertook transfection experiments. To establish a
good correlation between EMSA and transcription analysis,
preparation of nuclear extracts and transfection were always
done in parallel on the same cell cultures, in proliferation or
di¡erentiation conditions.
Transcriptional activity of the H4 motif was estimated by
comparison of normalized CAT enzyme production from
p606vimCAT and from p642vimCAT, since the only di¡er-
ence between the two plasmids is the presence of the H4 motif
between nt 3642 and 3606 in the latter. We con¢rmed that
the vimentin H4 motif stimulates transcription in C2C12 myo-
blasts (3^5-fold activation over p606vimCAT). When myo-
blasts di¡erentiated into myotubes, we observed, parallel to
the decrease in H4TF-1-like binding activity in nuclear ex-
tracts, a 2-fold reduction of transcriptional stimulation by
the H4 motif in transfected cells (Fig. 4). From these results,
we hypothesize that loss of interaction of the H4 motif with a
factor that may be H4TF-1, contributes to the downregula-
tion of vimentin gene expression during in vitro myogenesis.
4. Discussion
Myogenesis takes place in vivo during embryonal develop-
ment or in the adult organism upon muscle regeneration. It
has been extensively studied in vitro using various myogenic
cell lines and the molecular mechanisms which control muscle
gene induction have been relatively well unraveled, involving a
cascade of transcriptional activation initiated by the MyoD
family of basic helix-loop-helix (HLH) regulatory proteins
(for a review, see [11]). Upon serum starvation, myoblasts
turn on the synthesis of myogenin, which induces irreversible
withdrawal from the cell cycle and coordinate expression of
Fig. 3. Loss of binding to the vimentin H4 motif upon myoblast
di¡erentiation. Interaction of whole nuclear extracts from C3H
10T1/2 ¢broblasts (lane 1), C2C12 myoblasts (lane 2) and myotubes
(lane 3), with 32P-labeled vH4 probe. (A, B) EMSA, (A) in the ab-
sence or (B) in the presence of SP1 competitor. (C) Southwestern
blot. Arrowhead in (A) points to a protein^DNA complex which
disappears upon myogenic di¡erentiation of C2C12 cells.
Fig. 4. Decrease in transcriptional activity of the vimentin H4 motif
in C2C12 myotubes. Normalized CAT reporter gene activity, ob-
tained after transfection of C2C12 cells by p606vimCAT (open
bars) and p642vimCAT (¢lled bars), is represented as mean val-
ues þ S.E.M. For clarity the mean of p606vimCAT values is set to
1, so that p642vimCAT values are directly shown as fold activation
over p606vimCAT, due to the presence of the H4 motif.
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genes encoding sarcomeric proteins and muscle-speci¢c en-
zymes. Then, myoblasts fuse to generate postmitotic, multi-
nucleated myotubes with a characteristic contractile pheno-
type.
Several constituents of the cytoskeleton undergo rearrange-
ments upon myogenesis. We are interested in studying IF
protein synthesis during skeletal muscle di¡erentiation in vi-
tro. How repression of vimentin gene expression occurs in
these conditions is not clearly understood yet. Among several
transcription factors binding to the vimentin promoter, AP1
and NF-UB have been identi¢ed as positive regulators of vi-
mentin gene expression in proliferating cells [5]. It has been
suggested that in muscle cells, AP1 and MyoD functionally
antagonize each other through physical association between
Jun and MyoD [12], so that upon muscle di¡erentiation
MyoD might block AP1-dependent activation of the vimentin
promoter. However, no decrease in c-jun expression or AP1
binding activity was observed in C2C12 cells [13]. NF-UB was
reported to stimulate cell proliferation and to block muscle
di¡erentiation through activation of the cyclin D1 gene [14],
suggesting that the positive e¡ect of NF-UB on the vimentin
promoter may be counteracted during myogenesis. In other
works, NF-UB has been shown to stimulate myoblast fusion
and induction of muscle-speci¢c genes [15]. Thus, if AP1 and
NF-UB are involved in the downregulation of vimentin gene
expression upon myogenesis, this has not been unambiguously
demonstrated yet. In the present study, our interest has fo-
cused on a third regulatory element within the vimentin pro-
moter, namely the H4 motif. We show that a factor speci¢-
cally binding to this sequence in ¢broblast and myoblast
nuclear extracts exhibits apparent molecular weight and con-
ditions of binding to DNA in agreement with its being H4TF-
1. Upon myoblast fusion, binding of this factor is lost, where-
as transcriptional activation through the H4 motif decreases
2-fold. Residual activation in myotubes might rely upon SP1-
dependent complex formation. From these results we hy-
pothesize that the vimentin promoter is recognized and acti-
vated by H4TF-1 in myoblasts but not in myotubes, and that
this di¡erentiation stage-speci¢c, functional interaction con-
tributes to the downregulation of vimentin gene expression
during in vitro myogenesis. Diverse mutated versions of the
H4 motif have been studied but none of them allowed to
discriminate between H4TF-1 and SP1 binding [8,16,17]. Fur-
thermore, both factors were shown to protect the eight G
nucleotides on the complementary strand of the H4 motif
against in vitro methylation [10,17]. Taken together, these
data indicate that H4TF-1 and SP1 binding sites completely
overlap. In our study, involvement of H4TF-1 rather than
SP1 in di¡erentiation stage-speci¢c activity of the vimentin
H4 motif may be deduced from the fact that binding of
H4TF-1, not of SP1, is lost in myotube extracts.
H4TF-1 has been identi¢ed as a transcription factor bind-
ing to the human histone H4 gene [18], stimulating its tran-
scription 4^5-fold [8]. It does not bind to non-H4 histone
genes, and its abundance does not vary appreciably through-
out the cell cycle in proliferating ¢broblasts [19]. A distinct
factor controls S phase-induced histone H4 gene expression
but increases transcription only 2-fold [20]. Thus, H4TF-1 is
not a cell cycle-dependent regulator but it is required for
maximal transcription of the active histone H4 gene. It also
participates in transcriptional activation of other genes, such
as those encoding human and murine blood clotting factor
VII [16,17].
No antibody against H4TF-1 exists since the factor has
been only partially puri¢ed [10]. No candidate gene encoding
H4TF-1 has been identi¢ed. Thus, characterization of H4TF-
1 activity essentially relies upon indirect evidence. Our results
with the vimentin promoter reproduce observations done with
the histone H4 gene, that is the binding of a factor around 110
kDa, destabilized at low Mg2 concentrations, lost upon mu-
tation of 5P-CCCTCCCCC-3P to 5P-TCGTACTCC-3P in tar-
get sequence, not competed out by SP1 consensus [8^10]. It is
noteworthy that in the case of the human factor VII gene also,
two complexes are formed with the H4TF-1 binding motif in
EMSA, the more retarded one including SP1 [16]. We do not
observe interaction of the vimentin H4 motif with SP1 in
Southwestern blot experiment, probably because an additional
factor is required to form a stable complex with SP1, which
cannot be achieved after electrophoretic separation of the
proteins.
Some factors controlling muscle-speci¢c gene induction are
also found in undi¡erentiated myoblasts, i.e. the desmin myo-
tube-speci¢c enhancer binding factor identi¢ed by Gao et al.
[21]. Here, by studying the vimentin promoter, we have un-
covered H4TF-1 as a proliferating cell-speci¢c factor that dis-
appears upon fusion of growing myoblasts into di¡erentiated
myotubes. Interestingly, the H4TF-1 recognition site is
present in the promoters of other genes shown to be down-
regulated upon myogenesis, including c-fos, Id2A and Id3.
c-fos is involved in the positive control of cell proliferation
and may need to be repressed when myoblasts withdraw from
the cell cycle. MyoD actually downregulates transcription of
the c-fos gene upon muscle cell di¡erentiation [22]. Id proteins
are HLH transcription factors that lack DNA binding do-
mains. They inhibit myogenesis through sequestering of E
proteins required for the activation of muscle-speci¢c genes
by basic HLH myogenic factors [23]. Expression of Id2A
and Id3 is high in growing myoblasts and is dramatically
downregulated after the cells are induced to di¡erentiate
[24,25]. Thus, H4TF-1 might play a more general role during
myogenesis and contribute to the downregulation of several
genes upon muscle cell di¡erentiation, including immediate
early response genes like vimentin and c-fos, as well as genes
encoding members of the Id family of muscle di¡erentiation
inhibitors. Besides, within the vimentin promoter, where mul-
tiple factors potentially contribute to the regulation of gene
expression, H4TF-1 might be important, as in the context of a
few other genes, to achieve maximal transcription levels in
conditions where expression of the gene is switched on.
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